Prostate biopsy in selecting candidates for hemiablative focal therapy

Journal of Endourology

Volumn 24, Issue 5, 2010, Pages 849-853

  Tsivian, Matvey ^a   Hruza, Marcel ^b   Mouraviev, Vladimir ^a   Rassweiler, Jens ^b   Polascik, Thomas J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Heilbronn University   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER SCREENING; CLINICAL PROTOCOL; CLINICAL RESEARCH; CRYOABLATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ELASTOGRAPHY; EVIDENCE BASED PRACTICE; FOCAL THERAPY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; REVIEW; SENSITIVITY AND SPECIFICITY; TRANSRECTAL ULTRASONOGRAPHY; ULTRASOUND;

BIOPSY; HUMANS; MALE; NEOPLASM STAGING; PATIENT SELECTION; PROSTATE; PROSTATIC NEOPLASMS;

EID: 77952565795     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2009.0473     Document Type: Review

References (33)

1. Polascik TJ, Mouraviev V. Focal therapy for prostate cancer. Curr Opin Urol 2008;18:269-274.
2. Polascik TJ, Mayes JM, Schroeck FR, et al. Patient selection for hemiablative focal therapy of prostate cancer: Variables predictive of tumor unilaterality based upon radical prostatectomy. Cancer 2009;115:2104-2110.
3. Mouraviev V, Mayes JM, Sun L, et al. Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer. Cancer 2007; 110:906-910.
4. Tareen B, Godoy G, Sankin A, et al. Laterality alone should not drive selection of candidates for hemi-ablative focal therapy. J Urol 2009;181:1082-1090.
5. Tareen B, Godoy G, Sankin A, et al. Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer? BJU Int 2009;104:195-199.
6. Mayes JM, Mouraviev V, Sun L, et al. Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer? Urol Oncol 2009. Epub ahead of print.
7. Tsivian M, Kimura M, Sun L, et al. Predicting unilaterality of prostate cancer on routine diagnostic biopsy: Sextant versus extended. BJU Int 2009. Epub ahead of print.
8. Tsivian M, Moreira DM, Sun L, Mouraivev V, Kimura M, Moul JW, Polascik TJ. Biopsy accuracy in identifying unilateral prostate cancer depends on prostate weight. Urol Oncol (In press).
9. Onik G, Barzell W. Transperineal 3D mapping biopsy of the prostate: An essential tool in selecting patients for focal prostate cancer therapy. Urol Oncol 2008;26:506-510.
10. Bott SR, Henderson A, Halls JE, et al. Extensive transperineal template biopsies of prostate: Modified technique and results. Urology 2006;68:1037-1041.
11. Narayanan R, Werahera PN, Barqawi A, et al. Adaptation of a 3D prostate cancer atlas for transrectal ultrasound guided target-specific biopsy. Phys Med Biol 2008;53:N397-N406.
12. Zhan Y, Shen D, Zeng J, et al. Targeted prostate biopsy using statistical image analysis. IEEE Trans Med Imaging 2007;26: 779-788.
13. Ou Y, Shen D, Zeng J, et al. Sampling the spatial patterns of cancer: Optimized biopsy procedures for estimating prostate cancer volume and Gleason Score. Med Image Anal 2009;13: 609-620.
14. Paul R, Schö ler S, van Randenborgh H, et al. Morbidity of prostatic biopsy for different biopsy strategies: Is there a relation to core number and sampling region? Eur Urol 2004;45:450-456.
15. Scattoni V, Zlotta A, Montironi R, et al. Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: A critical analysis of the literature. Eur Urol 2007;52:1309-1322.
16. Satoh T, Matsumoto K, Fujita T, et al. Cancer core distribution in patients diagnosed by extended transperineal prostate biopsy. Urology 2005;66:114-118.
17. Kawakami S, Kihara K, Fujii Y, et al. Transrectal ultrasoundguided transperineal 14-core systematic biopsy detects apico-anterior cancer foci of T1c prostate cancer. Int J Urol 2004;11:613-618.
18. Bouye S, Potiron E, Puech P, et al. Transition zone and anterior stromal prostate cancers: Zone of origin and intraprostatic patterns of spread at histopathology. Prostate 2009;69: 105-113.
19. Merrick GS, Taubenslag W, Andreini H, et al. The morbidity of transperineal template-guided prostate mapping biopsy. BJU Int 2008;101:1524-1529.
20. Kawakami S, Yamamoto S, Numao N, et al. Direct comparison between transrectal and transperineal extended prostate biopsy for the detection of cancer. Int J Urol 2007;14: 719-724.
21. Emiliozzi P, Corsetti A, Tassi B, et al. Best approach for prostate cancer detection: A prospective study on transperineal versus transrectal six-core prostate biopsy. Urology 2003;61:961-966.
22. Takenaka A, Hara R, Ishimura T, et al. A prospective randomized comparison of diagnostic efficacy between transperineal and transrectal 12-core prostate biopsy. Prostate Cancer Prostatic Dis 2008;11:134-138.
23. Miller J, Perumalla C, Heap G. Complications of transrectal versus transperineal prostate biopsy. ANZ J Surg 2005;75: 48-50.
24. Moran BJ, Braccioforte MH, Conterato DJ. Re-biopsy of the prostate using a stereotactic transperineal technique. J Urol 2006;176:1376-1381.
25. Megwalu II, Ferguson GG, Wei JT, et al. Evaluation of a novel precision template-guided biopsy system for detecting prostate cancer. BJU Int 2008;102:546-550.
26. Blumenfeld P, Hata N, DiMaio S, et al. Transperineal prostate biopsy under magnetic resonance image guidance: A needle placement accuracy study. J Magn Reson Imaging 2007;26:688-694.
27. Baumann M, Mozer P, Daanen V, Troccaz J. Towards 3D ultrasound image based soft tissue tracking: a transrectal ultrasound prostate image alignment system. Med Image Comput Comput Assist Interv Int Conf Med Image Comput Comput Assist Interv 2007;10:26-33.
28. Stock C, Hruza M, Cresswell J, Rassweiler JJ. Transrectal ultrasound-guided biopsy of the prostate: Development of the procedure, current clinical practice, and introduction of self-embedding as a new way of processing biopsy cores. J Endourol 2008;22:1321-1329.
29. Umbehr M, Bachmann LM, Held U, et al. Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: A systematic review and meta-analysis. Eur Urol 2009;55:575-590.
30. Pondman KM, Fü tterer JJ, ten Haken B, et al. MR-guided biopsy of the prostate: An overview of techniques and a systematic review. Eur Urol 2008;54:517-527.
31. Aigner F, Pallwein L, Mitterberger M, et al. Contrastenhanced ultrasonography using cadence-contrast pulse sequencing technology for targeted biopsy of the prostate. BJU Int 2009;103:458-463.
32. Nelson ED, Slotoroff CB, Gomella LG, Halpern EJ. Targeted biopsy of the prostate: The impact of color Doppler imaging and elastography on prostate cancer detection and Gleason score. Urology 2007;70:1136-1140.
33. Bastian PJ, Carter BH, Bjartell A, et al. Insignificant prostate cancer and active surveillance: From definition to clinical implications. Eur Urol 2009;55:1321-1330.